Literature DB >> 24764720

Localized synchronous squamous cell carcinomas of the esophagus and hypopharynx treated with definitive concurrent chemoradiotherapy with a unified radiotherapy plan.

J B Wallach1, M M Rosenstein1, S Kalnicki1.   

Abstract

Because of common risk factors, synchronous squamous cell carcinomas of the esophagus and head and neck are common, and their concurrent presence can significantly complicate disease eradication and survival. Here, we report the case of a patient with a history of extensive tobacco and alcohol use who was diagnosed with a localized thoracic esophageal squamous cell carcinoma, and in whom positron-emission tomography-computed tomography discovered a nearby asymptomatic localized hypopharyngeal focus that was confirmed by biopsy to also be malignant. He was treated with definitive concurrent chemoradiotherapy in a single unified radiotherapy plan, with surgery reserved for salvage treatment. He currently remains in remission without a need for surgical salvage. However, significant concern remains for both treatment failure and development of another primary because of "field cancerization."

Entities:  

Keywords:  Synchronous squamous cell carcinomas; chemotherapy; esophageal cancer; field cancerization; hypopharyngeal cancer; radiotherapy

Year:  2014        PMID: 24764720      PMCID: PMC3997468          DOI: 10.3747/co.21.1844

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  13 in total

1.  Synchronous second primary tumors in 2,016 head and neck cancer patients: role of symptom-directed panendoscopy.

Authors:  Erlend Rennemo; Ulf Zätterström; Morten Boysen
Journal:  Laryngoscope       Date:  2011-02       Impact factor: 3.325

2.  Preoperative chemoradiotherapy for esophageal or junctional cancer.

Authors:  P van Hagen; M C C M Hulshof; J J B van Lanschot; E W Steyerberg; M I van Berge Henegouwen; B P L Wijnhoven; D J Richel; G A P Nieuwenhuijzen; G A P Hospers; J J Bonenkamp; M A Cuesta; R J B Blaisse; O R C Busch; F J W ten Kate; G-J Creemers; C J A Punt; J T M Plukker; H M W Verheul; E J Spillenaar Bilgen; H van Dekken; M J C van der Sangen; T Rozema; K Biermann; J C Beukema; A H M Piet; C M van Rij; J G Reinders; H W Tilanus; A van der Gaast
Journal:  N Engl J Med       Date:  2012-05-31       Impact factor: 91.245

3.  Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome.

Authors:  Allen M Chen; Leon M Chen; Andrew Vaughan; Radhika Sreeraman; D Gregory Farwell; Quang Luu; Derick H Lau; Kerri Stuart; James A Purdy; Srinivasan Vijayakumar
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-14       Impact factor: 7.038

4.  Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer.

Authors:  Devasena Anantharaman; Manuela Marron; Pagona Lagiou; Evangelia Samoli; Wolfgang Ahrens; Hermann Pohlabeln; Alena Slamova; Miriam Schejbalova; Franco Merletti; Lorenzo Richiardi; Kristina Kjaerheim; Xavier Castellsague; Antonio Agudo; Renato Talamini; Luigi Barzan; Tatiana V Macfarlane; Martin Tickle; Lorenzo Simonato; Cristina Canova; David I Conway; Patricia A McKinney; Peter Thomson; Ariana Znaor; Claire M Healy; Bernard E McCartan; Mia Hashibe; Paul Brennan; Gary J Macfarlane
Journal:  Oral Oncol       Date:  2011-08       Impact factor: 5.337

5.  Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group.

Authors:  J S Cooper; M D Guo; A Herskovic; J S Macdonald; J A Martenson; M Al-Sarraf; R Byhardt; A H Russell; J J Beitler; S Spencer; S O Asbell; M V Graham; L L Leichman
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

6.  Risk factors for developing synchronous esophageal neoplasia in patients with head and neck cancer.

Authors:  Wen-Lun Wang; Ching-Tai Lee; Yi-Chia Lee; Tzer-Zen Hwang; Chih-Chun Wang; Jau-Chung Hwang; Chi-Ming Tai; Chi-Yang Chang; Shang-Shyue Tsai; Cheng-Ping Wang; Jenq-Yuh Ko; Jaw-Town Lin
Journal:  Head Neck       Date:  2011-01       Impact factor: 3.147

7.  High incidence of synchronous cancer of the oral cavity and the upper gastrointestinal tract.

Authors:  K Fukuzawa; Y Noguchi; T Yoshikawa; A Saito; C Doi; T Makino; Y Takanashi; T Ito; A Tsuburaya
Journal:  Cancer Lett       Date:  1999-10-01       Impact factor: 8.679

Review 8.  Clinical analysis of multiple primary malignancies of the hypopharynx and esophagus.

Authors:  T Kohmura; Y Hasegawa; H Matsuura; A Terada; M Takahashi; T Nakashima
Journal:  Am J Otolaryngol       Date:  2001 Mar-Apr       Impact factor: 1.808

9.  Trends over three decades of the risk of second primary cancer among patients with head and neck cancer.

Authors:  Jérémie Jégu; Florence Binder-Foucard; Christian Borel; Michel Velten
Journal:  Oral Oncol       Date:  2012-07-26       Impact factor: 5.337

10.  Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience.

Authors:  Victor S Wang; Jason L Hornick; Joe A Sepulveda; Rie Mauer; John M Poneros
Journal:  Gastrointest Endosc       Date:  2009-01-10       Impact factor: 9.427

View more
  5 in total

1.  Efficacy of Staged Treatment Strategy for Patients with Synchronous Double Cancers of the Esophagus and Head and Neck: A Retrospective Study.

Authors:  Akira Matsumoto; Masayuki Watanabe; Hironobu Shigaki; Koujiro Nishida; Shinji Mine; Takeshi Sano; Katsuhiko Yanaga
Journal:  World J Surg       Date:  2016-02       Impact factor: 3.352

2.  Xenogeneic acellular dermal matrix in combination with pectoralis major myocutaneous flap reconstructs hypopharynx and cervical esophagus.

Authors:  Danhui Yin; Qinglai Tang; Shuang Wang; Shisheng Li; Xiangbo He; Jiajia Liu; Bingbing Liu; Mi Yang; Xinming Yang
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-31       Impact factor: 2.503

3.  Treatment of Squamous Cell Carcinoma of the Esophagus Synchronously Associated with Head and Neck Cancer.

Authors:  Masaru Morita; Akinori Egashira; Y U Nakaji; Masaki Kagawa; Masahiko Sugiyama; Daisuke Yoshida; Mitsuhiko Ota; Masahiko Ikebe; Muneyuki Masuda; Yojiro Inoue; Naonobu Kunitake; Yasushi Toh
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

4.  Clinical outcomes of synchronous head and neck and esophageal cancer.

Authors:  Jae Won Park; Sang-Wook Lee
Journal:  Radiat Oncol J       Date:  2015-09-30

5.  Clinical characteristics, treatments, and prognosis of patients with multiple primary carcinoma of head and neck.

Authors:  Kun Liu; Xin-Xin Zhang; Nan-Xiang Chen; Wen-Ming Wu; Jia-Ling Wang; De-Liang Huang; Jian-Dong Zhao; Shi-Ming Yang; Lin Ma
Journal:  Chin Med J (Engl)       Date:  2020-02-05       Impact factor: 2.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.